Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide (VOD-DF) ODM derived from

  1. 2/24/12 2/24/12 -
  2. 7/25/15 7/25/15 - Martin Dugas
Uploaded on:

July 25, 2015

To request one please log in.
License :
Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Veno-Occlusive Disease Prophylactic Use of Defibrotide NCT00272948

Eligibility Veno-Occlusive Disease Prophylactic Use of Defibrotide NCT00272948

Inclusion Criteria
Age below 18 years
myeloablative conditioning and autologous or allogeneic stem cell transplantation with at least one of the following risk factors for VOD: Pre-existing liver disease, Second myeloablative HSCT, History of treatment with gemtuzumab ozogamicin (MYLOTARGO, GO, CMA-676, Wyeth), Allogeneic HSCT for leukemia beyond the second relapse, Osteopetrosis (OP), Conditioning with busulfan and melphalan, Macrophage activating syndromes (MAS, like hemophagocytic lymphohistiocytosis, Griscelli, Chediak-Higashi), Adrenoleukodystrophy (ALD)
Exclusion Criteria
Pregnant patients
Patients who are transplanted but do not fulfill any of the above mentioned criteria
Medical Concepts

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial